316 related articles for article (PubMed ID: 12241874)
1. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study.
Thomas SL; Wheeler JG; Hall AJ
Lancet; 2002 Aug; 360(9334):678-82. PubMed ID: 12241874
[TBL] [Abstract][Full Text] [Related]
2. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
[TBL] [Abstract][Full Text] [Related]
3. The effect of vaccination on the epidemiology of varicella zoster virus.
Edmunds WJ; Brisson M
J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
[TBL] [Abstract][Full Text] [Related]
4. Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data.
Forbes H; Douglas I; Finn A; Breuer J; Bhaskaran K; Smeeth L; Packer S; Langan SM; Mansfield KE; Marlow R; Whitaker H; Warren-Gash C
BMJ; 2020 Jan; 368():l6987. PubMed ID: 31969318
[TBL] [Abstract][Full Text] [Related]
5. Modelling the impact of varicella vaccination on varicella and zoster.
Karhunen M; Leino T; Salo H; Davidkin I; Kilpi T; Auranen K
Epidemiol Infect; 2010 Apr; 138(4):469-81. PubMed ID: 19796447
[TBL] [Abstract][Full Text] [Related]
6. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.
Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF
Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
[TBL] [Abstract][Full Text] [Related]
8. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
Hardy I; Gershon AA; Steinberg SP; LaRussa P
N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of herpes zoster among children immunized with varicella vaccine: results from a nested case-control study.
Tseng HF; Smith N; Marcy SM; Sy LS; Chao CR; Jacobsen SJ
Pediatr Infect Dis J; 2010 Mar; 29(3):205-8. PubMed ID: 19952977
[TBL] [Abstract][Full Text] [Related]
10. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
van Hoek AJ; Melegaro A; Zagheni E; Edmunds WJ; Gay N
Vaccine; 2011 Mar; 29(13):2411-20. PubMed ID: 21277405
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox.
Gershon AA; LaRussa P; Steinberg S; Mervish N; Lo SH; Meier P
J Infect Dis; 1996 Feb; 173(2):450-3. PubMed ID: 8568309
[TBL] [Abstract][Full Text] [Related]
12. Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program.
Gans H; Chemaly RF
BMC Infect Dis; 2021 Jan; 21(1):46. PubMed ID: 33430796
[TBL] [Abstract][Full Text] [Related]
13. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child.
Uebe B; Sauerbrei A; Burdach S; Horneff G
Eur J Pediatr; 2002 Aug; 161(8):442-4. PubMed ID: 12172829
[TBL] [Abstract][Full Text] [Related]
14. Contacts with children and young people and adult risk of suffering herpes zoster.
Salleras M; Domínguez A; Soldevila N; Prat A; Garrido P; Torner N; Borrás E; Salleras L
Vaccine; 2011 Oct; 29(44):7602-5. PubMed ID: 21889558
[TBL] [Abstract][Full Text] [Related]
15. Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination.
Betta M; Laurino M; Pugliese A; Guzzetta G; Landi A; Manfredi P
Proc Biol Sci; 2016 Mar; 283(1826):20160054. PubMed ID: 26984627
[TBL] [Abstract][Full Text] [Related]
16. Do the health-care workers gain protection against herpes zoster infection? A 6-year population-based study in Taiwan.
Wu CY; Hu HY; Huang N; Pu CY; Shen HC; Chou YJ
J Dermatol; 2010 May; 37(5):463-70. PubMed ID: 20536652
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility to varicella-zoster virus in Thai children and young adults.
Kositanont U; Wasi C; Oonsombat P; Suvatte V; Thongcharoen P
Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):414-20. PubMed ID: 3006266
[TBL] [Abstract][Full Text] [Related]
18. Varicella zoster vaccines.
Creed R; Satyaprakash A; Ravanfar P
Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
[TBL] [Abstract][Full Text] [Related]
19. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
Goldman GS
Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
[TBL] [Abstract][Full Text] [Related]
20. Prospects for use of a varicella vaccine in adults.
Hardy IR; Gershon AA
Infect Dis Clin North Am; 1990 Mar; 4(1):159-73. PubMed ID: 2155261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
